Achlorhydria is associated with gastric microbial overgrowth and development of cancer: Lessons learned from the gastrin knockout mouse

References

• Edkins J. S. On the chemical mechanism of gastric secretion. Proc Roy Soc B 1905; 76: 376
   Google Scholar
• Edkins J. S. The chemical mechanism of gastric secretion. J Physiol 1906; 34: 133–44
   PubMedGoogle Scholar
• Gregory R. A., Tracy H. J. The constitution and properties of two gastrins extracted from hog antral mucosa. Gut 1964; 5: 103–17
   PubMed Web of Science ®Google Scholar
• Mutt V., Jorpes J. E. Structure of porcine cholecystokinin‐pancreozymin. 1. Cleavage with thrombin and with trypsin. Eur J Biochem 1968; 6: 156–62
   PubMedGoogle Scholar
• Rehfeld J. F. The new biology of gastrointestinal hormones. Physiol Rev 1998; 78: 1087–108
   PubMed Web of Science ®Google Scholar
• Grossman M. I. Gastrin, cholecystokinin, and secretin act on one receptor. Lancet 1970; 1((7656))1088–9
   Google Scholar
• Kopin A. S., Lee Y. ‐M., McBride E. W., Miller L. J., Lu M., Lin H. Y., et al. Expression cloning and characterization of the canine parietal cell gastrin receptor. Proc Natl Acad Sci USA 1992; 89: 3605–9
   PubMed Web of Science ®Google Scholar
• Ito M., Iwata N., Taniguchi T., Murayama T., Chihara K., Matsui T. Functional characterization of two cholecystokinin‐B/gastrin receptor isoforms: a preferential splice donor site in the human receptor gene. Cell Growth Differ 1994; 5: 1127–35
   PubMedGoogle Scholar
• Song I., Brown D. R., Wiltshire R. N., Gantz I., Trent J. M., Yamada T. The human gastrin/cholecystokinin type B receptor gene: alternative splice donor site in exon 4 generates two variant mRNAs. Proc Natl Acad Sci USA 1993; 90((19))9085–9
   Google Scholar
• Miyake A. A truncated isoform of human CCK‐B/gastrin receptor generated by alternative usage of a novel exon. Biochem Biophys Res Commun 1995; 208: 230–7
   PubMed Web of Science ®Google Scholar
• Hellmich M. R., Rui X. L., Hellmich H. L., Fleming R. Y., Evers B. M., Townsend C. M., Jr. Human colorectal cancers express a constitutively active cholecystokinin‐B/gastrin receptor that stimulates cell growth. J Biol Chem 2000; 275((41))32122–8
   Google Scholar
• Smith J. P., Stanley W. B., Verderame M. F., Zagon I. S. The functional significance of the cholecystokinin‐C (CCK‐C) receptor in human pancreatic cancer. Pancreas 2004; 29: 271–7
   PubMed Web of Science ®Google Scholar
• Baldwin G. S., Chandler R., Scanlon D. B., Weinstock J. Identification of a gastrin binding protein in porcine gastric mucosal membranes by covalent cross‐linking with iodinated gastrin. J Biol Chem 1986; 261((26))12252–7
   Google Scholar
• Singh P., Lu X., Cobb S., Miller B. T., Tarasova N., Varro A., et al. Progastrin 1‐80 stimulates growth of intestinal epithelial cells in vitro via high‐affinity binding sites. Am J Physiol Gastrointest Liver Physiol 2003; 284((2))G328–39
   Google Scholar
• Seva C., Dickinson C. J., Yamada T. Growth‐promoting effects of glycine‐extended progastrin. Science 1994; 265((5170))410–12
   Google Scholar
• Johnson L. R. Functional development of the stomach. Annu Rev Physiol 1985; 47: 199–215
   PubMedGoogle Scholar
• Johnson L. R., Lichtenberger L. M., Copeland E. M., Dudrick S. J., Castro G. A. Action of gastrin on gastrointestinal structure and function. Gastroenterology 1975; 68((5 Pt 1))1184–92
   Google Scholar
• Johnson L. R., Chandler A. M. RNA and DNA of gastric and duodenal mucosa in antrectomized and gastrin‐treated rats. Am J Physiol 1973; 224: 937–40
   PubMedGoogle Scholar
• Oscarson J., Håkanson R., Liedberg G., Lundqvist G., Sundler F., Thorell J. Variated serum gastrin concentration: trophic effects on the gastrointestinal tract of the rat. Acta Physiol Scand 1979; 475: 2–27
   Google Scholar
• Wank S. A. G protein‐coupled receptors in gastrointestinal physiology. I. CCK receptors: an exemplary family. Am J Physiol 1998; 274((4 Pt 1))G607–13
   Google Scholar
• Herranz R. Cholecystokinin antagonists: pharmacological and therapeutic potential. Med Res Rev 2003; 23: 559–605
   PubMed Web of Science ®Google Scholar
• Thompson J. C., Fender H. R., Watson L. C., Villar H. V. The effects on gastrin and gastric secretion of five current operations for duodenal ulcer. Ann Surg 1976; 183((5))599–608
   Google Scholar
• Koh T. J., Goldenring J. R., Ito S., Mashimo H., Kopin A. S., Varro A., et al. Gastrin deficiency results in altered gastric differentiation and decreased colonic proliferation in mice. Gastroenterology 1997; 113: 1015–25
   PubMed Web of Science ®Google Scholar
• Friis‐Hansen L., Sundler F., Li Y., Gillespie P. J., Greenson J. L., Owyang C., et al. Impaired gastric acid secretion in gastrin deficient mice. Am J Physiol 1998; 274: G561–8
   PubMed Web of Science ®Google Scholar
• Nagata A., Ito M., Iwata N., Kuno J., Takano H., Minowa O., et al. G‐protein‐coupled cholecystokinin‐B/gastrin receptors are responsible for physiological cell growth of the stomach in vivo. Proc Natl Acad Sci USA 1996; 93: 11825–30
   PubMed Web of Science ®Google Scholar
• Langhans N., Rindi G., Chiu M., Rehfeld J. F., Ardman B., Beiborn M., et al. Abnormal gastric histology and decreased acid production in cholecystokinin‐B/gastrin receptor deficient mice. Gastroenterology 1997; 112: 280–6
   PubMed Web of Science ®Google Scholar
• Kopin A. S., Mathes W. F., McBride E. W., Nguyen M., Al‐Haider W., Schmitz F., et al. The cholecystokinin‐A receptor mediates inhibition of food intake yet is not essential for the maintenance of body weight. J Clin Invest 1999; 103: 383–91
   PubMed Web of Science ®Google Scholar
• Håkanson R., Liedberg G. The role of endogenous gastrin in the activation of gastric histidine decarboxylase in the rat. Effect of antrectomy and vagal denervation. Eur J Pharmacol 1970; 12((1))94–103
   Google Scholar
• Håkanson R., Chen D., Sundler F. The ECL cells. Physiology of the gastrointestinal tract, L. R Johnson. Raven Press, New York 1994; 1171–84, 3rd ed
   Google Scholar
• Becker J. M., Rosen C. B., Kelly K. A., Micevych P. E., Cranley B., Go V. L. Canine mucosal antrectomy. Arch Surg 1986; 121: 824–30
   PubMedGoogle Scholar
• Lloyd K. C. K., Raybould H. E., Taché Y., Walsh J. H. Role of gastrin, histamin, and acetylcholine in the gastric phase of acid secretion anesthetized rats. Am J Physiol 1992; 262: G747–55
   Google Scholar
• Ding X. Q., Kitano M., Håkanson R. Sustained cholecystokinin‐B/gastrin receptor blockade does not impair basal or histamine‐stimulated acid secretion in chronic gastric fistula rats. Pharmacol Toxicol 1998; 82: 177–82
   Google Scholar
• Chen D., Zhao C. ‐M., Håkanson R., Samuelson L. C., Rehfeld J. F., Friis‐Hansen L. Altered control of gastric acid secretion in gastrin‐cholecystokinin double mutant mice. Gastroenterology 2004; 126: 476–87
   PubMed Web of Science ®Google Scholar
• Chen D., Zhao C. M., Al‐Haider W., Håkanson R., Rehfeld J. F., Kopin A. S. Differentiation of gastric ECL cells is altered in CCK(2) receptor‐deficient mice. Gastroenterology 2002; 123((2))577–85
   Google Scholar
• Chen D., Zhao C. ‐M., Al‐Haider W., Håkanson R., Rehfeld J. F., Kopin A. S. Differentiation of gastric ECL cells is altered in CCK2 receptor deficient mice. Gastroenterology 2002; 123: 577–85
   PubMed Web of Science ®Google Scholar
• Costa T., Herz A. Antagonists with negative intrinsic activity at delta opioid receptors coupled to GTP‐binding proteins. Proc Natl Acad Sci USA 1989; 86((19))7321–5
   Google Scholar
• Karam S. M., Leblond C. P. Dynamics of epithelial cells in the corpus of the mouse stomach. V. Behavior of entero‐endocrine and caveolated cells: general conclusions on cell kinetics in the oxyntic epithelium. Anat Rec 1993; 236: 333–40
   Google Scholar
• Hinkle K. L., Bane G. C., Jazayeri A., Samuelson L. C. Enhanced calcium signaling and acid secretion in parietal cells isolated from gastrin‐deficient mice. Am J Physiol Gastrointest Liver Physiol 2003; 284: G145–53
   Google Scholar
• Rehfeld J. F. Cholecystokinin. Best Pract Res Clin Endocrinol Metab 2004; 18: 569–86
   PubMed Web of Science ®Google Scholar
• Soll A. H., Yamada T., Park J., Thomas L. P. Release of somatostatin‐like immunoreactivity from canine fundic mucosal cells in primary culture. Am J Physiol 1984; 247((5 Pt 1))G558–66
   Google Scholar
• Schmidt W. E., Schenk S., Nustede R., Holst J. J., Fölsch U. R., Creutzfeldt W. Cholecystokinin is a negative regulator of gastric acid secretion and postprandial release of gastrin in humans. Gastroenterology 1994; 107: 1610–20
   PubMedGoogle Scholar
• Friis‐Hansen L., Wierup N., Rehfeld J. F., Sundler F. The G‐cell in gastrin and gastrin‐cholecystokinin knockout animals. Cell Tissue Res 2005; 321: 141–6
   Google Scholar
• Schmitz F., Göke M. N., Otte J. M., Schrader H., Reimann B., Kruse M. L., et al. Cellular expression of CCK‐A and CCK‐B/gastrin receptors in human gastric mucosa. Regul Pept 2001; 102: 101–10
   PubMedGoogle Scholar
• Soll A. H., Amirian D. A., Park J., Elashoff J. D., Yamada T. Cholecystokinin potently releases somatostatin from canine fundic mucosal cells in short‐term culture. Am J Physiol 1985; 248((5 Pt 1))G569–73
   Google Scholar
• Lloyd K. C., Maxwell V., Chuang C. N., Wong H. C., Soll A. H., Walsh J. H. Somatostatin is released in response to cholecystokinin by activation of type A CCK receptors. Peptides 1994; 15: 223–7
   Google Scholar
• Fung L. C., Greenberg G. R. Characterization of somatostatin receptor subtypes mediating inhibition of nutrient‐stimulated gastric acid and gastrin in dogs. Regul Pept 1997; 68: 197–203
   Google Scholar
• Hersey S. J., Sachs G. Gastric acid secretion. Physiol Rev 1995; 75: 155–89
   PubMed Web of Science ®Google Scholar
• Aihara T., Nakamura Y., Taketo M. M., Matsui M., Okabe S. Cholinergically stimulated gastric acid secretion is mediated by M3 and M5, but not M1, muscarinic acetylcholine receptors in mice. Am J Physiol Gastrointest Liver Physiol 2005 Feb 3
   Google Scholar
• Pfeiffer A., Rochlitz H., Noelke B., Tacke R., Moser U., Mutschler E., et al. Muscarinic receptors mediating acid secretion in isolated rat gastric parietal cells are of M3 type. Gastroenterology 1990; 98: 218–22
   PubMed Web of Science ®Google Scholar
• Schubert M. L. Neural and paracrine regulation of gastrin secretion. Gastrin, J Walsh. Raven Press, New York 1993; 129–37
   Google Scholar
• Lindström E., Björkqvist M., Boketoft A., Chen D., Zhao C. M., Kimura K., et al. Neurohormonal regulation of histamine and pancreastatin secretion from isolated rat stomach ECL cells. Regul Pept 1997; 71: 73–86
   PubMed Web of Science ®Google Scholar
• Mungan Z., Hammer R. A., Akarca U. S., Komaki G., Ertan A., Arimura A. Effect of PACAP on gastric acid secretion in rats. Peptides 1995; 16: 1051–6
   Google Scholar
• Zeng N., Athmann C., Kang T., Lyu R. M., Walsh J. H., Ohning G. V., et al. PACAP type I receptor activation regulates ECL cells and gastric acid secretion. J Clin Invest 1999; 104: 1383–91
   PubMed Web of Science ®Google Scholar
• Kobayashi T., Tonai S., Ishihara Y., Koga R., Okabe S., Watanabe T. Abnormal functional and morphological regulation of the gastric mucosa in histamine H2 receptor‐deficient mice. J Clin Invest 2000; 105: 1741–9
   Google Scholar
• Stanley M. D., Coalson R. E., Grossman M. I., Johnson L. R. Influence of secretin and pentagastrin on acid secretion and parietal cell number in rats. Gastroenterology 1972; 63: 264
   PubMed Web of Science ®Google Scholar
• Tielemans Y., Håkanson R., Sundler F., Willems G. Proliferation of enterochromaffin‐like cells in omeprazole‐treated hypergastrinemic rats. Gastroenterology 1989; 96: 723–9
   PubMed Web of Science ®Google Scholar
• Koh T. J., Chen D. Gastrin as a growth factor in the gastrointestinal tract. Regul Pept 2000; 93: 37–44
   PubMed Web of Science ®Google Scholar
• Willems G., Vansteenkiste Y., Limbosch J. M. Stimulating effect of gastrin on cell proliferation kinetics in canine fundic mucosa. Gastroenterology 1972; 62: 583–9
   PubMed Web of Science ®Google Scholar
• Nakajima T., Konda Y., Izumi Y., Kanai M., Hayashi N., Chiba T., et al. Gastrin stimulates the growth of gastric pit cell precursors by inducing its own receptors. Am J Physiol 2002; 282: G359–66
   Google Scholar
• Friis‐Hansen L., Schjerling C. K., Dornonville de la Cour C., Rehfeld J. F., Håkanson R. A molecular portrait of the ECL cell. 2005
   Google Scholar
• Ramamoorthy S., Stepan V., Todisco A. Intracellular mechanisms mediating the anti‐apoptotic action of gastrin. Biochem Biophys Res Commun 2004; 323: 44–8
   Google Scholar
• Tsutsui S., Shinomura Y., Higashiyama S., Higashimoto Y., Miyazaki Y., Kanayama S., et al. Induction of heparin binding epidermal growth factor‐like growth factor and amphiregulin mRNAs by gastrin in the rat stomach. Biochem Biophys Res Commun 1997; 235: 520–3
   Google Scholar
• Miyazaki Y., Shinomura Y., Tsutsui S., Zushi S., Higashimoto Y., Kanayama S., et al. Gastrin induces heparin‐binding epidermal growth factor‐like growth factor in rat gastric epithelial cells transfected with gastrin receptor. Gastroenterology 1999; 116: 78–89
   PubMed Web of Science ®Google Scholar
• Wang T. C., Dangler C. A., Chen D., Goldenring J. R., Koh T., Raychowdhury R., et al. Synergistic interaction between hypergastrinemia and Helicobacter infection in a mouse model of gastric cancer. Gastroenterology 2000; 118: 36–47
   PubMed Web of Science ®Google Scholar
• Friis‐Hansen L., Rieneck K., Nilsson H. ‐O., Wadström T., Rehfeld J. F. Gastric inflammation, metaplasia and tumor development in gastrin deficient mice. Gastroenterology 2006
   Google Scholar
• Beaumont W. Case of a wounded stomach. Medical Recorder 1825; 8: 14–19
   Google Scholar
• Evenepoel P. Alteration in digestion and absorption of nutrients during profound acid suppression. Best Pract Res Clin Gastroenterol 2001; 15: 539–51
   Google Scholar
• Friis‐Hansen L., Wierup N., Rehfeld J. F., Sundler F. Reduced ghrelin, IAPP and PYY expression in the stomach of gastrin‐cholecystokinin knockout mice. Endocrinology 2005; 146: 4464–71
   Google Scholar
• Husebye E. The pathogenesis of gastrointestinal bacterial overgrowth. Chemotherapy 2005; 51(Suppl 1)1–22
   PubMed Web of Science ®Google Scholar
• Stockbruegger R. W., Cotton P. B., Menon G. G., Beilby J. O., Bartholomew B. A., Hill M. J., et al. Pernicious anaemia, intragastric bacterial overgrowth, and possible consequences. Scand J Gastroenterol 1984; 19: 355–64
   PubMed Web of Science ®Google Scholar
• Giannella R. A., Broitman S. A., Zamcheck N. Gastric acid barrier to ingested microorganisms in man: studies in vivo and in vitro. Gut 1972; 13: 251–6
   PubMed Web of Science ®Google Scholar
• Brinton L. A., Gridley G., Hrubec Z., Hoover R., Fraumeni J. F., Jr. Cancer risk following pernicious anaemia. Br J Cancer 1989; 59: 810–13
   PubMed Web of Science ®Google Scholar
• Hsing A. W., Hansson L. E., McLaughlin J. K., Nyren O., Blot W. J., Ekbom A., et al. Pernicious anemia and subsequent cancer. A population‐based cohort study. Cancer 1993; 71: 745–50
   PubMed Web of Science ®Google Scholar
• Lundegardh G., Adami H. O., Helmick C., Zack M., Meirik O. Stomach cancer after partial gastrectomy for benign ulcer disease. N Engl J Med 1988; 319: 195–200
   PubMed Web of Science ®Google Scholar
• Caygill C. P., Hill M. J., Kirkham J. S., Northfield T. C. Mortality from gastric cancer following gastric surgery for peptic ulcer. Lancet 1986; 1((8487))929–31
   Google Scholar
• Viste A., Björnestad E., Opheim P., Skarstein A., Thunold J., Hartveit F., et al. Risk of carcinoma following gastric operations for benign disease. A historical cohort study of 3470 patients. Lancet 1986; 2((8505))502–5
   Google Scholar
• Caygill C. P., Hill M. J. Malignancy following surgery for benign peptic disease: a review. Ital J Gastroenterol 1992; 24: 218–24
   Google Scholar
• Kondo K. Duodenogastric reflux and gastric stump carcinoma. Gastric Cancer 2002; 5: 16–22
   PubMedGoogle Scholar
• von Holstein C. S. Long‐term prognosis after partial gastrectomy for gastroduodenal ulcer. World J Surg 2000; 24: 307–14
   Google Scholar
• Zavros Y., Rieder G., Ferguson A., Samuelson L. C., Merchant J. L. Genetic or chemical hypochlorhydria is associated with inflammation that modulates parietal and G‐cell populations in mice. Gastroenterology 2002; 122: 119–33
   PubMed Web of Science ®Google Scholar
• Sun F. J., Kaur S., Ziemer D., Banerjee S., Samuelson L. C., De Lisle R. C. Decreased gastric bacterial killing and up‐regulation of protective genes in small intestine in gastrin‐deficient mouse. Dig Dis Sci 2003; 48: 976–85
   Google Scholar
• Zavros Y., Eaton K. A., Kang W., Rathinavelu S., Katukuri V., Kao J. Y., et al. Chronic gastritis in the hypochlorhydric gastrin‐deficient mouse progresses to adenocarcinoma. Oncogene 2005 Feb 14
   Google Scholar
• Meining A., Morgner A., Miehlke S., Bayerdorffer E., Stolte M. Atrophy‐metaplasia‐dysplasia‐carcinoma sequence in the stomach: a reality or merely an hypothesis?. Best Pract Res Clin Gastroenterol 2001; 15: 983–98
   PubMed Web of Science ®Google Scholar
• Correa P. Human gastric carcinogenesis: a multistep and multifactorial process – First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res 1992; 52: 6735–40
   PubMed Web of Science ®Google Scholar
• Howden C. W., Hunt R. H. Relationship between gastric secretion and infection. Gut 1987; 28: 96–107
   PubMed Web of Science ®Google Scholar
• Yeomans N. D., Brimblecombe R. W., Elder J., Heatley R. V., Misiewicz J. J., Northfield T. C., et al. Effects of acid suppression on microbial flora of upper gut. Dig Dis Sci 1995; 40((2 Suppl))81S–95S
   Google Scholar
• Reed P. I., Smith P. L., Haines K., House F. R., Walters C. L. Effect of cimetidine on gastric juice N‐nitrosamine concentration. Lancet 1981; 2((8246))553–6
   Google Scholar
• Stockbrugger R. W., Cotton P. B., Eugenides N., Bartholomew B. A., Hill M. J., Walters C. L. Intragastric nitrites, nitrosamines, and bacterial overgrowth during cimetidine treatment. Gut 1982; 23: 1048–54
   PubMed Web of Science ®Google Scholar
• Vermeer I. T., Gerrits M. M., Moonen E. J., Engels L. G., Dallinga J. W., Kleinjans J. C., et al. Helicobacter pylori does not mediate the formation of carcinogenic N‐nitrosamines. Helicobacter 2002; 7: 163–9
   Google Scholar
• Schlag P., Bockler R., Peter M. Nitrite and nitrosamines in gastric juice: risk factors for gastric cancer?. Scand J Gastroenterol 1982; 17: 145–50
   PubMed Web of Science ®Google Scholar
• Kang W., Rathinavelu S., Samuelson L. C., Merchant J. L. Interferon gamma induction of gastric mucous neck cell hypertrophy. Lab Invest 2005; 85: 702–15
   Google Scholar
• Judd L. M., Alderman B. M., Howlett M., Shulkes A., Dow C., Moverley J., et al. Gastric cancer development in mice lacking the SHP2 binding site on the IL‐6 family co‐receptor gp130. Gastroenterology 2004; 126: 196–207
   PubMed Web of Science ®Google Scholar
• Jenkins B. J., Grail D., Nheu T., Najdovska M., Wang B., Waring P., et al. Hyperactivation of Stat3 in gp130 mutant mice promotes gastric hyperproliferation and desensitizes TGF‐beta signaling. Nat Med 2005; 11: 845–52
   PubMed Web of Science ®Google Scholar
• Howlett M., Judd L. M., Jenkins B., La Gruta N. L., Grail D., Ernst M., et al. Differential regulation of gastric tumor growth by cytokines that signal exclusively through the coreceptor gp130. Gastroenterology 2005; 129: 1005–18
   Google Scholar
• Mishra L., Shetty K., Tang Y., Stuart A., Byers S. W. The role of TGF‐beta and Wnt signaling in gastrointestinal stem cells and cancer. Oncogene 2005; 24((37))5775–89
   Google Scholar
• Ramalho‐Santos M., Melton D. A., McMahon A. P. Hedgehog signals regulate multiple aspects of gastrointestinal development. Development 2000; 127: 2763–72
   PubMed Web of Science ®Google Scholar
• Wang J., Lin W., Popko B., Campbell I. L. Inducible production of interferon‐gamma in the developing brain causes cerebellar dysplasia with activation of the Sonic hedgehog pathway. Mol Cell Neurosci 2004; 27: 489–96
   Google Scholar
• Lin W., Kemper A., McCarthy K. D., Pytel P., Wang J. P., Campbell I. L., et al. Interferon‐gamma induced medulloblastoma in the developing cerebellum. J Neurosci 2004; 24((45))10074–83
   Google Scholar
• Shiotani A., Iishi H., Uedo N., Ishiguro S., Tatsuta M., Nakae Y., et al. Evidence that loss of sonic hedgehog is an indicator of Helicobacter pylori‐induced atrophic gastritis progressing to gastric cancer. Am J Gastroenterol 2005; 100: 581–7
   PubMed Web of Science ®Google Scholar
• Rozengurt E., Walsh J. H. Gastrin, CCK, signaling, and cancer. Annu Rev Physiol 2001; 63: 49–76
   PubMed Web of Science ®Google Scholar
• Rengifo‐Cam W., Singh P. Role of progastrins and gastrins and their receptors in GI and pancreatic cancers: targets for treatment. Curr Pharm Des 2004; 10: 2345–58
   PubMedGoogle Scholar
• Ferrand A., Wang T. C. Gastrin and cancer: a review. Cancer Lett 2005 Jul 26
   Google Scholar
• Franic T. V., Judd L. M., Nguyen N. V., Samuelson L. C., Loveland K. L., Giraud A. S., et al. Growth factors associated with gastric mucosal hypertrophy in autoimmune gastritis. Am J Physiol Gastrointest Liver Physiol 2004 17; 287: G910–18
   PubMed Web of Science ®Google Scholar
• Bower J. M., Camble R., Gregory H., Gerring E. L., Willshire I. R. The inhibition of gastric acid secretion by epidermal growth factor. Experientia 1975; 31: 825–6
   PubMedGoogle Scholar
• Xu G. P., Reed P. I. N‐nitroso compounds in fresh gastric juice and their relation to intragastric pH and nitrite employing an improved analytical method. Carcinogenesis 1993; 14: 2547–51
   PubMed Web of Science ®Google Scholar
• Risch H. A., Jain M., Choi N. W., Fodor J. G., Pfeiffer C. J., Howe G. R., et al. Dietary factors and the incidence of cancer of the stomach. Am J Epidemiol 1985; 122: 947–59
   PubMed Web of Science ®Google Scholar
• Gonzalez C. A., Riboli E., Badosa J., Batiste E., Cardona T., Pita S., et al. Nutritional factors and gastric cancer in Spain. Am J Epidemiol 1994; 139: 466–73
   PubMed Web of Science ®Google Scholar
• Zavros Y., Rieder G., Ferguson A., Merchant J. L. Gastritis and hypergastrinemia due to Acinetobacter lwoffii in mice. Infect Immun 2002; 70: 2630–9
   Google Scholar
• Lamberts R., Brunner G., Solcia E. Effects of very long (up to 10 years) proton pump blockade on human gastric mucosa. Digestion 2001; 64: 205–13
   PubMedGoogle Scholar
• Gillen D., McColl K. E. Problems associated with the clinical use of proton pump inhibitors. Pharmacol Toxicol 2001; 89: 281–6
   Google Scholar
• Håkanson R., Sundler F. Proposed mechanism of induction of gastric carcinoids: the gastrin hypothesis. Eur J Clin Invest 1990; 20(Suppl 1)S65–71
   PubMedGoogle Scholar
• Dimmler A., Brabletz T., Hlubek F., Hafner M., Rau T., Kirchner T., et al. Transcription of sonic hedgehog, a potential factor for gastric morphogenesis and gastric mucosa maintenance, is up‐regulated in acidic conditions. Lab Invest 2003; 83: 1829–37
   PubMed Web of Science ®Google Scholar
• Eda A., Osawa H., Yanaka I., Satoh K., Mutoh H., Kihira K., et al. Expression of homeobox gene CDX2 precedes that of CDX1 during the progression of intestinal metaplasia. J Gastroenterol 2002; 37: 94–100
   PubMed Web of Science ®Google Scholar
• Faller G., Dimmler A., Rau T., Spaderna S., Hlubek F., Jung A., et al. Evidence for acid‐induced loss of Cdx2 expression in duodenal gastric metaplasia. J Pathol 2004; 203: 904–8
   Google Scholar
• Klinkenberg‐Knol E. C., Nelis F., Dent J., Snel P., Mitchell B., Prichard P., et al. Long‐term omeprazole treatment in resistant gastroesophageal reflux disease: efficacy, safety, and influence on gastric mucosa. Gastroenterology 2000; 118: 661–9
   PubMed Web of Science ®Google Scholar
• Møller H., Nissen A., Mosbech J. Use of cimetidine and other peptic ulcer drugs in Denmark 1977–1990 with analysis of the risk of gastric cancer among cimetidine users. Gut 1992; 33: 1166–9
   PubMed Web of Science ®Google Scholar
• Tutuian R., Katz P. O., Castell D. O. Nocturnal acid breakthrough: pH, drugs and bugs. Eur J Gastroenterol Hepatol 2004; 16: 441–3
   PubMedGoogle Scholar
• Hansson L. E. Risk of stomach cancer in patients with peptic ulcer disease. World J Surg 2000; 24: 315–20
   Google Scholar
• Kodama K., Sumii K., Kawano M., Kido T., Nojima K., Sumii M., et al. Gastric juice nitrite and vitamin C in patients with gastric cancer and atrophic gastritis: is low acidity solely responsible for cancer risk?. Eur J Gastroenterol Hepatol 2003; 15: 987–93
   PubMedGoogle Scholar
• Cunningham R., Dale B., Undy B., Gaunt N. Proton pump inhibitors as a risk factor for Clostridium difficile diarrhoea. J Hosp Infect 2003; 54: 243–5
   PubMed Web of Science ®Google Scholar
• Martinsen T. C., Bergh K., Waldum H. L. Gastric juice: a barrier against infectious diseases. Basic Clin Pharmacol Toxicol 2005; 96: 94–102
   PubMed Web of Science ®Google Scholar
• Sarker S. A., Gyr K. Non‐immunological defence mechanisms of the gut. Gut 1992; 33: 987–93
   PubMed Web of Science ®Google Scholar
• Lewis S. J., Franco S., Young G., O'Keefe S. J. Altered bowel function and duodenal bacterial overgrowth in patients treated with omeprazole. Aliment Pharmacol Ther 1996; 10: 557–61
   PubMed Web of Science ®Google Scholar
• Williams C., McColl K. E. Review article: proton pump inhibitors and bacterial overgrowth. Aliment Pharmacol Ther 2006; 23: 3–10
   PubMed Web of Science ®Google Scholar